LifeMD:Freedom Capital Maintains Buy Rating, Raises PT to $10 from $8

jueves, 12 de marzo de 2026, 1:31 pm ET1 min de lectura
LFMD--

LifeMD:Freedom Capital Maintains Buy Rating, Raises PT to $10 from $8

LifeMD:Freedom Capital Maintains Buy Rating, Raises PT to $10 from $8

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios